Table 1

Patient characteristics (n=371)

n (%)
Gender
 Male181 (49%)
 Female190 (51%)
Age at death (years: mean, SD)72 (14)
Diagnosis
 Cancer289 (79%)
 Non-cancer76 (21%)
Place of death
 Hospital164 (44%)
 Hospice207 (56%)
Duration of the dying phase (hours: median, range)25, 0–279
Symptoms at the start of the CPD
Level of consciousness
 Conscious112 (30%)
 Semiconscious175 (47%)
 Unconscious80 (22%)
Restlessness132 (36%)
Confusion86 (24%)
Respiratory tract secretions68 (19%)
Treatment
Opioid use during the last day before the start of the CPD282 (76%)
 Morphine equivalent daily dose (mg/24 hours) (median, range)75 (2–4200)
Opioid use during the dying phase345 (93%)
 Morphine equivalent daily dose (mg/24 hours) (median, range)108 (0–10 790)
Use of palliative sedation during the dying phase162 (44%)
Fluid intake
Total daily fluid intake last week before start of the CPD (mL) (median, range)625 (125–3375)
 0–499 mL/day74 (22%)
 500–999 mL/day117 (35%)
 ≥1000 mL/day144 (43%)
Total daily fluid intake last day before start of the CPD (mL) (median, range)625 (125–2875)
 0–499 mL/day187 (55%)
 500–999 mL/day70 (21%)
 ≥1000 mL/day81 (24%)
Total daily fluid intake during the dying phase (mL) (median, range)250 (6–2250)
 0–249 mL/day257 (69%)
 250–499 mL/day61 (16%)
 ≥500 mL/day53 (15%)
Total daily fluid intake 48–25 hours before death (mL) (median, range)334 (42–2500)
 0–249 mL/day190 (51%)
 250–499 mL/day44 (12%)
 ≥500 mL/day121 (33%)
  • CPD, Care Program for the Dying.